Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
47.3M
-
Shares change
-
-980K
-
Total reported value, excl. options
-
$35.3M
-
Value change
-
-$922K
-
Put/Call ratio
-
0.24
-
Number of buys
-
9
-
Number of sells
-
-21
-
Price
-
$0.75
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q4 2024
60 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q4 2024.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.3M shares
of 55.4M outstanding shares and own 85.42% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (29.2M shares), FMR LLC (5.92M shares), HarbourVest Partners LLC (3.51M shares), STATE OF WISCONSIN INVESTMENT BOARD (1.86M shares), Siren, L.L.C. (1.32M shares), VANGUARD GROUP INC (1.1M shares), Blue Owl Capital Holdings LP (1.06M shares), 683 Capital Management, LLC (600K shares), MILLENNIUM MANAGEMENT LLC (521K shares), and 72 Investment Holdings, LLC (353K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.